BENZOPYRAZOLVERBINDUNG

European patent · EP4086247 · In force

Register entry

Publication number
EP4086247
Application number
EP20909915
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 30, 2020
Published
Nov 9, 2022
Granted
Oct 14, 2026
Protection ends at the latest
Dec 29, 2040
Next annual fee due
Dec 31, 2026
IPC classes
C07D 231/56 (2006.01)
C07D 401/04 (2006.01)
C07D 403/04 (2006.01)
C07D 405/04 (2006.01)
C07D 413/04 (2006.01)
C07D 417/04 (2006.01)
C07D 471/04 (2006.01)
C07D 487/04 (2006.01)
C07D 498/04 (2006.01)
A61P 19/02 (2006.01)
A61P 29/00 (2006.01)
A61K 31/416 (2006.01)
A61K 31/497 (2006.01)
A61K 31/519 (2006.01)
Priority
CN 201911412430 31.12.2019
CN 202011389082 01.12.2020
PCT application
PCT/CN2020/141632 30.12.2020
PCT publication
WO2021/136429 08.07.2021
Filing language
Chinese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 14, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 14.10.2026

Parties

Holder

Shenzhen Optimum Biological Technology Co., Ltd

B37, 11th Floor, Xihai Mingzhu Building No.1 Taoyuan East Road, Dawangshan Community Nantou Street, Nanshan District, Shenzhen, Guangdong 518052, CN

Inventor

SU, Sheng

Shanghai 200131, CN

WEI, Xiawei

Chengdu, Sichuan 610041, CN

LUO, Yunfu

Shanghai 200131, CN

ZHANG, Guoli

Shanghai 200131, CN

WANG, Yong

Shanghai 200131, CN

CHEN, Shuhui

Shanghai 200131, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.